 |
 |
|
|
|
 |
|
 |
 |
|
|
ScyFIX is a multi-national company based in Minneapolis, Minnesota USA, that distributes eye therapy products using micro current stimulation, which we consider to be the most effective available treatment for Macular Degeneration and other degenerative eye diseases. MD is a major cause for the deterioration of eyesight in older age groups, effecting many millions of people. It is estimated that 5% of the entire world population will develop a form of MD. Our products are CE Mark approved. The ScyFIX solution addresses Macular Degeneration, Retinitis Pigmentosa, Diabetic Retinopathy, Glaucoma, and CMV-Retinitis. More than 2000 people have been successfully treated with MCS Therapy. ScyFIX intends to become the world leader in the distribution of effective, non-invasive therapies for the treatment of chronic eye disorders.
Studies have shown that micro-current stimulation can improve the vision for 85% of those suffering from Macular Degeneration, 83% of those suffering from Stargardt's disease,
and 2/3 of those suffering from Retinitis Pigmentosa. In patients who have improved, an increase in brightness and a decrease in fogginess are usually the first changes noted.
Other changes include an increase in visual acuity, enhanced color perception and a decrease in the size and/or density of the blind spot.
Importantly, micro-current stimulation has also proven to expand the visual field for both Macular Degeneration and Retinitis Pigmentosa.
ScyFIX’s lead product is the ScyFIX 600. This device is available for the medical professional as part of his/her practice, as well as for individual consumer/patients as a stand-alone home treatment unit. The device comes complete with an instructions. The ScyFIX 600 MCS device is offered through the on-line shop on this web site.
|
|
| |
 |
|
|
|
|
|
